A Five Year Plan of Enhanced HCV Monitoring, Primary Care-Based Workforce Development, Rapid Scale‐up of HCV Treatment and Public Health Policy Action in HIV Positive Individuals Within Australia
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C; HIV infections
- Focus Therapeutic Use
- Acronyms CEASE
- 16 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Jun 2016 Study design changed from interventional to observational; Cross- Sectional keyword added.
- 07 Jun 2016 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.